Search Results - "Burty, C"

Occult hepatitis B infection in patients infected with HIV: Report of two cases of hepatitis B reactivation and prevalence in a hospital cohort by Bloquel, B, Jeulin, H, Burty, C, Letranchant, L, Rabaud, C, Venard, V

“…Patients co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are particularly at risk of hepatitis B reactivation. Two cases of…”
Get full text

Tolerability of Postexposure Prophylaxis with the Combination of Zidovudine-Lamivudine and Lopinavir-Ritonavir for HIV Infection by Rabaud, Christian, Burty, Christine, Grandidier, Michel, Christian, Bernard, Penalba, Christian, Béguinot, Isabelle, Jeanmaire, Henri, May, Thierry

“…Tolerability of the combination of zidovudine-lamivudine and lopinavir-ritonavir as postexposure prophylaxis (PEP) for human immunodeficiency virus infection…”
Get full text

Relevance of fluoroquinolone use in Nancy's hospital. Results of the first turn by Desmots, E, Demore, B, Doco-Lecompte, T, Burty, C, Rabaud, C, May, T

“…The objective was to evaluate the good use of fluoroquinolones in a hospital with a relevance review in the context of an approach to evaluation of…”
Get full text

P643 Causes of liver related death in HIV-infected patients in France: mortality 2005 Survey by Salmon, D, Lewden, C, Bonnet, F, Rosenthal, E, Morlat, P, May, T, Burty, C, Costagliola, D, Jougla, E, Semaille, C, Chěne, G, Cacoub, P

Get full text

Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005 : The Mortalité 2000 and 2005 Surveys (ANRS EN19 and Mortavic) by LEWDEN, Charlotte, MAY, Thierry, CACOUB, Patrice, CHENE, Geneviève, ROSENTHAL, Eric, BURTY, Christine, BONNET, Fabrice, COSTAGLIOLA, Dominique, JOUGLA, Eric, SEMAILLE, Caroline, MORLAT, Philippe, SALMON, Dominique

“…The multicenter national Mortalité 2005 survey aimed at describing the distribution of causes of death among HIV-infected adults in France in 2005 and its…”
Get full text

Changes in Cancer Mortality among HIV-Infected Patients: The Mortalité 2005 Survey by Bonnet, Fabrice, Burty, Christine, Lewden, Charlotte, Costagliola, Dominique, May, Thierry, Bouteloup, Vincent, Rosenthal, Eric, Jougla, Eric, Cacoub, Patrice, Salmon, Dominique, Chéne, Geneviéve, Morlat, Philippe

“…Background. The goal of the current study was to describe the distribution and characteristics of malignancy-related deaths among human immunodeficiency virus…”
Get full text

Antibiolor, the Lorraine antibiology network: Update on 7 years of activity by May, T., Burty, C., Demoré, B., Aissa, N., Birgé, J., Rabaud, C., Doco-Lecompte, T.

“…The objective of the study was to assess the activity of the Antibiolor network, created in 2003, to promote antibiotic stewardship in Lorraine, and comply…”
Get full text

Relevance of fluoroquinolone use in a French teaching hospital by Rughoo, L., Doco-Lecompte, T., Henard, S., Burty, C., Desmots, E., Letranchant, L., Rabaud, C., May, T., Demoré, B.

“…The objective of our study was to assess the good use of fluoroquinolone (FQ) in a French teaching hospital by a two round relevance review before and after…”
Get full text

Liver‐related deaths in HIV‐infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalité 2005 survey, ANRS EN19) by Rosenthal, E, Salmon‐Céron, D, Lewden, C, Bouteloup, V, Pialoux, G, Bonnet, F, Karmochkine, M, May, T, François, M, Burty, C, Jougla, E, Costagliola, D, Morlat, P, Chêne, G, Cacoub, P

“…Background More than 10 years after the introduction of combination antiretroviral therapy (cART), we examined the trend in the proportion of deaths caused by…”
Get full text

Relevance of fluoroquinolone use in Lorraine: results of the first survey by Doco-Lecompte, T, Demoré, B, Burty, C, Rondelot, G, Scheid, P, Zuck, P, Simon, L, Letranchant, L, Robert, C, Frentiu, E, Petitfrère, M, Simplot, B, Bevilacqua, S, Voltz, C, Rabaud, C, May, T

“…The Antibiolor network assessed the good use of fluoroquinolones (FQ) in the French Lorraine region by a relevance review. At the beginning of 2008, the…”
Get full text

Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen by Pavel, Simona, Burty, Christine, Alcaraz, Isabelle, de la Tribonnière, Xavier, Baclet, Véronique, Ajana, Faiza, Mouton, Yves, Rabaud, Christian, Yazdanpanah, Yazdan

“…In France, post-exposure prophylaxis (PEP) is provided to patients after HIV occupational or sexual exposure. Current guidelines recommend the use of combined…”
Get full text

How does loss to follow‐up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates by Lanoy, E, Lewden, C, Lièvre, L, Tattevin, P, Boileau, J, Aouba, A, Chêne, G, Costagliola, D

“…Objective We aimed to retrieve the vital status of patients lost to follow‐up (LFU), with no further visits for at least 12 months, for the 34 835 patients in…”
Get full text

Impact of corrective measures on fluoroquinolones prescriptions for urinary tract infections during a 2-round relevance study by Gendrin, V, Letranchant, L, Hénard, S, Frentiu, E, Demore, B, Burty, C, May, T, Doco-Lecompte, T

“…Evaluating the impact of corrective measures on fluoroquinolones (FQ) prescriptions for urinary tract infections (UTI) during a 2-round relevance study on a…”
Get full text

Revue de pertinence des fluoroquinolones en Lorraine : résultats de la première évaluation by Doco-Lecompte, T., Demoré, B., Burty, C., Rondelot, G., Scheid, P., Zuck, P., Simon, L., Letranchant, L., Robert, C., Frentiu, E., Petitfrère, M., Simplot, B., Bevilacqua, S., Voltz, C., Rabaud, C., May, T.

“…Évaluer le bon usage des fluoroquinolones (FQ) à l’échelon d’une région par une revue de pertinence organisée par le réseau Antibiolor. Début 2008, les…”
Get full text

Amélioration de la prescription des fluoroquinolones dans les infections urinaires. Revue de pertinence à deux tours by Gendrin, V., Letranchant, L., Hénard, S., Frentiu, E., Demore, B., Burty, C., May, T., Doco-Lecompte, T.

“…Evaluating the impact of corrective measures on fluoroquinolones (FQ) prescriptions for urinary tract infections (UTI) during a 2-round relevance study on a…”
Get full text

Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial) by MOLINA, Jean-Michel, JOURNOT, Valérie, FURCO, André, PALMER, Pierre, DE CASTRO, Nathalie, RAFFI, Francois, MORLAT, Philippe, MAY, Thierry, RANCINAN, Corinne, CHENE, Geneviève

“…Once-daily combination therapy with emtricitabine, didanosine and efavirenz has been highly effective in clinical trials but its long-term efficacy and safety…”
Get full text

Revue de pertinence de la prescription des fluoroquinolones au CHU de Nancy : résultats du premier tour by Desmots, E., Demore, B., Doco-Lecompte, T., Burty, C., Rabaud, C., May, T.

“…L’objectif était d’évaluer le bon usage des fluoroquinolones au sein du CHU de Nancy en participant à une revue de pertinence dans le cadre d’une démarche…”
Get full text

Revue de pertinence de la prescription des fluoroquinolones au CHU de Nancy: résultats du premier tour: Numéro spécial Microbiologie - Virologie - Infectiologie by DESMOTS, E, DEMORE, B, DOCO-LECOMPTE, T, BURTY, C, RABAUD, C, MAY, T

Get full text

Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir by LASTERE, Stephane, DALBAN, Cecile, COLLIN, Gilles, DESCAMPS, Diane, GIRARD, Pierre-Marie, CLAVEL, Francois, COSTAGLIOLA, Dominique, BRUN-VEZINET, Francoise

“…We evaluated the impact of genetic changes within p6Gag gene on the virological response (VR, mean decrease in plasma viral load at week 12) to unboosted…”
Get full text

Causes de décès par cancer en France en 2005 des adultes infectés par le VIH : Enquête Mortalité 2005, ANRS-EN19, en collaboration avec Mortavic by Bonnet, F., Rosenthal, E., Burty, C., Cacoub, P., Lewden, C., Salmon, D., May, T., Costagliola, D., Jougla, E., Semaille, C., Chêne, G., Morlat, P.

Get full text